🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 67% of ingredients have research evidence
A Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

1 Serving Size
60 Servings
Other Combinations Product Type
67% Evidence Coverage

Supplement Facts — Evidence Check

455 mg (15% DV)
📊 Market median: 500.0mg (159 products)
Median 500.0mg This product: 455mg
30 mg (50% DV)
✅ Within RDA (0.3× RDA of 90 mg) 📚 245 studies (Tier A: 6, B: 97)
RDA 90mg This product: 30mg UL 2000mg
15 mg (50% DV)
✅ 1.4× RDA — within safe limits 📚 258 studies (Tier A: 6, B: 134)
RDA 11mg This product: 15mg UL 40mg

Other Ingredients

Gelatin

Label Claims — Verification

Nutrient
All Other
Structure/Function
All Other (100% of products) Structure/Function (90% of products) Nutrient (73% of products)

Target Groups

Adult (18 - 50 Years)

Product Information

📋 Directions for Use

Directions: Take 1 capsule daily, or during a breakout take 1 capsule up to 8 times per day, or as advised by your doctor.

⚠️ Warnings & Precautions

Caution: If you suffer from any health problems or on medications consult a physician before using.

Keep out of reach of children.

Always take only as directed. If symptoms persist or you have side effects see your healthcare professional.

🧪 Formulation Notes

Formulated to fight HSV1 and HSV2 herpes simplex virus. Cold sore complex

L-Lysine, Vitamin C & Zinc

Made in New Zealand from imported ingredients

Additional Information

Store in a cool dry place.

Product Details

UPC / SKU 9 421904 081826
DSLD Entry Date 2024-01-24
Product Type Other Combinations
Form Capsule
DSLD ID 306093
Data Updated 2026-04-11

Research Evidence

3 Research Sources
74 Avg Quality Score
3 Meta Analysis
A Antifibrinolytics (lysine analogues) for the prevention of bleeding in people with haematological disorders
Meta Analysis The Cochrane database of systematic reviews 2026
B Antifibrinolytics (lysine analogues) for the prevention of bleeding in people with haematological disorders
Meta Analysis The Cochrane database of systematic reviews 2016
B Antifibrinolytics (lysine analogues) for the prevention of bleeding in patients with haematological disorders
Meta Analysis The Cochrane database of systematic reviews 2013
View all evidence for Lysine →

Compare Similar Products

View all Lysine products →